acute myeloid leukemia

News

Venetoclax Plus Gilteritinib Shows High Rates of mCRC in Patients with AML

07/19/2021

Venetoclax combined with gilteritinib demonstrates high mCRC rates and antileukemic activity in patients with FLT3-mutated relapsed or refractory (R/R) acute myeloid leukemia (AML) in an updated phase 1b study.

Venetoclax combined with...

07/19/2021

Oncology

Videos

Real-World Treatment Patterns, FLT3 Testing, and Outcomes in AML

01/14/2021

Amer Zeidan, MBBS, MHS, discusses results from a retrospective study examining FLT3 testing trends, treatment patterns, and overall survival in relapsed/refractory AML.

Amer Zeidan, MBBS, MHS,...

01/14/2021

Journal of Clinical Pathways

Diagnostic Dilemmas

An Atypical Chronic Ulcer Caused by Acute Myeloid Leukemia

04/12/2019

Danijela Semenič

Nataša Aleksovska

Atypical chronic wounds are challenging for clinicians because of their identification, diagnosis, and treatment. These wounds may reflect an underlying systemic or malignant disease; therefore, an accurate diagnosis and initiation of the...

Atypical chronic wounds are...

04/12/2019

Wounds

Perspectives

The Evolution of Care for Acute Myeloid Leukemia and the Challenges of Defining Value

05/21/2018

William J Cardarelli, PharmD

Abstract: Adult acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. Distinct subtypes of AML have been defined based on morphology, immunophenotyping, and molecular genetics. AML usually progresses...

...

05/21/2018

Journal of Clinical Pathways